EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis
The prevention and management of bleeding and thrombosis in patients with cirrhosis
poses several difficult clinical questions. These Clinical Practice Guidelines have been …
poses several difficult clinical questions. These Clinical Practice Guidelines have been …
[HTML][HTML] Bleeding and thrombotic complications in patients with cirrhosis: a state-of-the-art appraisal
PE Rautou, SH Caldwell, E Villa - Clinical Gastroenterology and …, 2023 - Elsevier
Much has evolved over the past 25 years regarding our understanding of the coagulopathy
of liver disease. Paradoxically, this form of coagulopathy is relatively hypercoagulability …
of liver disease. Paradoxically, this form of coagulopathy is relatively hypercoagulability …
[HTML][HTML] An update on the global use of risk assessment models and thromboprophylaxis in hospitalized patients with medical illnesses from the world thrombosis day …
G Forgo, E Micieli, W Ageno, LA Castellucci… - Journal of Thrombosis …, 2022 - Elsevier
Introduction Venous thromboembolism (VTE) is a leading cause of cardiovascular morbidity
and mortality. The majority of VTE events are hospital‐associated. In 2008, the …
and mortality. The majority of VTE events are hospital‐associated. In 2008, the …
[HTML][HTML] Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: guidance from the SSC of the ISTH
LN Roberts, V Hernandez‐Gea, M Magnusson… - Journal of Thrombosis …, 2022 - Elsevier
Hospital‐associated venous thromboembolism (HA‐VTE) is a major cause of morbidity and
mortality and is internationally recognized as a significant patient safety issue. While …
mortality and is internationally recognized as a significant patient safety issue. While …
Haemostatic alterations in patients with cirrhosis and hepatocellular carcinoma: laboratory evidence and clinical implications
Venous thrombosis is a frequent complication in cancer and is associated with high
morbidity and mortality. Hepatocellular carcinoma (HCC) is the most common primary liver …
morbidity and mortality. Hepatocellular carcinoma (HCC) is the most common primary liver …
[HTML][HTML] Incidence and prevalence of venous thromboembolism in chronic liver disease: A systematic review and meta-analysis
Background and aims Historically, bleeding was thought to be a frequent and fatal
complication of liver disease. However, thrombosis due to coagulation disorders in cirrhosis …
complication of liver disease. However, thrombosis due to coagulation disorders in cirrhosis …
Portal Vein Thrombosis: State-of-the-Art Review
A Boccatonda, S Gentilini, E Zanata, C Simion… - Journal of Clinical …, 2024 - mdpi.com
Background: Portal vein thrombosis (PVT) is a rare disease with an estimated incidence of 2
to 4 cases per 100,000 inhabitants. The most common predisposing conditions for PVT are …
to 4 cases per 100,000 inhabitants. The most common predisposing conditions for PVT are …
Safety and efficacy of venous thromboembolism prophylaxis in patients with cirrhosis: A systematic review and meta‐analysis
A Pasta, F Calabrese, S Labanca, S Marenco… - Liver …, 2023 - Wiley Online Library
Abstract Background & Aims Patients with cirrhosis are considered in a haemostatic
balance, though weaker than in normal subjects. In these patients, however, the use of …
balance, though weaker than in normal subjects. In these patients, however, the use of …
[HTML][HTML] Thromboelastography does not predict outcome in different etiologies of cirrhosis
Essentials• Global hemostasis tests generally indicate preserved hemostatic function in
cirrhotic patients.• Here we present thromboelastography test results of 270 patients of …
cirrhotic patients.• Here we present thromboelastography test results of 270 patients of …
Hypercoagulability in end-stage liver disease: review of epidemiology, etiology, and management
In this review, we analyze the epidemiology of thromboses related to end-stage liver disease
(ESLD), discuss causes of hypercoagulability, describe susceptible populations, and …
(ESLD), discuss causes of hypercoagulability, describe susceptible populations, and …